Insulin Aspart

Preferred Label : Insulin Aspart;

NCIt synonyms : Insulin Aspart Recombinant;

NCIt definition : A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin aspart inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin aspart also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05);

UNII : D933668QVX;

CAS number : 116094-23-6;

Drug name : Novolog;

Chemical formula : C256H381N65O79S6;

Details

Origin ID

C47563;

UMLS CUI

C0123677;

Automatic exact mappings (from CISMeF team)
- Product containing insulin aspart (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Insulin aspart (substance) [SNOMED CT concept]
- Product containing insulin aspart (medicinal product) [SNOMED CT concept]
- insulin aspart [ATC Code]
- insulin aspart [ATC Code]
Validated automatic mappings to BTNT
- insulin aspart [ATC Code]
- insulin aspart [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
has_target
- Insulin Receptor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients